Daniel Guinart, MD

  • 3Articles
  • 21.1KReads
  • 2020–2022Active
  • 10Collaborators
  • 51Citations

About

Daniel Guinart, MD, is affiliated with the Division of Psychiatry Research at Zucker Hillside Hospital, Northwell Health, and the Institute for Behavioral Science at the Feinstein Institute for Medical Research in New York. Additionally, Guinart is connected to the Department of Psychiatry at Zucker School of Medicine at Northwell/Hofstra and the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) at Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, and Universitat Autònoma de Barcelona in Spain. Guinart has contributed to research on schizophrenia and schizoaffective disorders and psychiatry, publishing articles between 2020 and 2022.

Publications

JCP
Reasons for Switching Antipsychotic Treatments
Original Research

Reasons for Switching Antipsychotic Treatments

September 5, 2022

Based on prescription records and prescriber notes, almost half of antipsychotic switches were due to side effects, and women were especially likely to be switched due to intolerability or...
, , , et al
JCP
Review Article

Outcomes of NMS With Depot Versus Oral Antipsychotics

November 24, 2020

Is the advantage of longer-term medication release with long-acting injectable antipsychotics offset by an increased risk of more prolonged and severe neuroleptic malignant syndrome? This systematic review and pooled...
, , , et al
JCP
ASCP Corner

Antipsychotic Polypharmacy in Schizophrenia: Why Not?

April 28, 2020

Antipsychotic polypharmacy in schizophrenia is common, but is it supported by evidence? And why is there an apparent disconnect between efficacy and effectiveness? This ASCP Corner article considers those...
,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe